Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
543904:BOM
Mankind Pharma Ltd
₹2,270.35
-0.94%
(-21.50) 1D
Apr 24, 12:08:52 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
₹2,301.45
High
₹2,317.20
Low
₹2,269.10
Mkt. cap
937.82B
Avg. vol.
36.70K
Volume
8.17K
Dividend
0.04%
Quarterly dividend
₹0.25
Ex dividend date
Aug 8, 2025
P/E ratio
52.73
52-wk high
₹2,726.75
52-wk low
₹1,909.90
EPS
₹43.05
No. of employees
20K
News stories
From sources across the web
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees19.6K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
30.79B
35.70B
36.97B
35.67B
Cost of goods sold
8.75B
10.54B
10.62B
9.78B
Cost of revenue
8.75B
10.54B
10.62B
9.78B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.16B
7.83B
8.25B
8.24B
Operating expense
17.52B
18.89B
19.35B
18.92B
Total operating expenses
26.27B
29.42B
29.98B
28.70B
Operating income
4.52B
6.28B
7.00B
6.97B
Other non operating income
2.51B
798.80M
918.70M
727.50M
EBT including unusual items
5.15B
5.40B
6.24B
5.09B
EBT excluding unusual items
5.15B
5.40B
6.24B
6.16B
Income tax expense
864.40M
958.70M
1.04B
951.20M
Effective tax rate
16.77%
17.74%
16.64%
18.69%
Other operating expenses
8.05B
8.87B
8.88B
8.46B
Net income
4.21B
4.38B
5.12B
4.09B
Net profit margin
13.66%
12.28%
13.84%
11.46%
Earnings per share
10.29
10.60
12.38
11.99
Interest and investment income
-
-
-
-
Interest expense
-1.91B
-1.71B
-1.70B
-1.57B
Net interest expenses
-1.91B
-1.71B
-1.70B
-1.57B
Depreciation and amortization charges
2.31B
2.19B
2.22B
2.23B
EBITDA
6.08B
7.74B
9.20B
8.42B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer